Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma (2019)
Fonte: EBioMedicine. Unidade: FCF
Assuntos: HETEROGENEIDADE, MELANOMA
ABNT
SMALLEY, Inna et al. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma. EBioMedicine, v. 48, p. 178-190, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ebiom.2019.09.023. Acesso em: 27 ago. 2024.APA
Smalley, I., Kim, E., Li, J., Spence, P., Wyatt, C., Eroglu, Z., et al. (2019). Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma. EBioMedicine, 48, 178-190. doi:10.1016/j.ebiom.2019.09.023NLM
Smalley I, Kim E, Li J, Spence P, Wyatt C, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma [Internet]. EBioMedicine. 2019 ; 48 178-190.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1016/j.ebiom.2019.09.023Vancouver
Smalley I, Kim E, Li J, Spence P, Wyatt C, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma [Internet]. EBioMedicine. 2019 ; 48 178-190.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1016/j.ebiom.2019.09.023